I am happy to share that I successfully completed the MIT Sloan program “Artificial Intelligence in Health Care”, also supported by the MIT J-Clinic, focused on AI technology suitable for health care use cases, its applications, limitations, and industry opportunities.
The potential of artificial intelligence (AI) to transform health care — through the work of both organizational leaders and medical professionals — is increasingly evident as more real-world clinical applications emerge.
As patient data sets grow, manual analysis becomes less feasible. AI has the power to efficiently process data far beyond our own capacity, and has already enabled innovation in areas including chemotherapy regimens, patient care, breast cancer risk, and even ICU mortality prediction.
The program intends to equip health care leaders with a grounded understanding of the potential for AI innovations in the health care industry. Techniques such as natural language processing, data analytics, and machine learning have been investigated across contexts, including disease diagnosis and hospital management.
